SCHEMBL3148506

SCHEMBL3148506

N[Pt](N)(N)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22661010 0.93
SCHEMBL3247394 0.83
SCHEMBL633464 0.83
SCHEMBL1072350 0.83
SCHEMBL5838 0.83
Hydrochloric Acid SCHEMBL17700573 0.77
SCHEMBL2231323 0.77
Hydrochloric Acid SCHEMBL22661008 0.77
Hydrochloric Acid SCHEMBL22661014 0.77
SCHEMBL301443 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1420775-B1 PLATINUM COMPLEXES AND THEIR USES IN THERAPY YISSUM RES DEV CO (IL) 2010-02-17 EP disclosed
US-7122668-B2 Platinum complexes and their use in therapy YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2006-10-17 US disclosed
US-20050090478-A1 Platinum complexes and their use in cancer treatment YISSUM RESEARCH DEVELOPMENT COMPANY OF THE (IL) 2005-04-28 US disclosed
EP-1420775-A1 PLATINUM COMPLEXES AND THEIR USE IN CANCER TREATMENT YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-05-26 EP disclosed
WO-2003017998-A1 PLATINUM COMPLEXES AND THEIR USE IN CANCER TREATMENT YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2003-03-06 WO disclosed